Upload
grace-noviyanthi-sinambela
View
217
Download
0
Embed Size (px)
Citation preview
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
1/20
Strategic Priorities of theWHO Cardiovascular
Disease Programme
Dr. Rina Amelia, MARS
Dept of Community Medicine
Block: Cardiovascular
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
2/20
The WHO Programme on Cardiovascular Diseases
(CVD) is concerned with prevention, managementand monitoring of CVD globally.
It aims to develop global strategies to reduce theincidence, morbidity and mortality of CVD by
effectively reducing CVD risk factors and their determinants
developing cost effective and equitable health care
innovations for management of CVD monitoring trends of CVD and their risk factors
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
3/20
CVD is the name for the group of disorders
of the heart and blood vessels and include:
Hypertension (high blood pressure)
Coronary heart disease (heart attack)
Cerebrovascular disease (stroke)
Peripheral vascular disease
Heart failure
Rheumatic heart disease Congenital heart disease
Cardiomyopathies
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
4/20
Facts
In 1999 CVD contributed to a third of globaldeaths.
In 1999, low and middle income countries
contributed to 78% of CVD deaths.By 2010 CVD is estimated to be the leading
cause of death in developing countries.
Heart disease has no geographic, gender orsocio-economic boundaries.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
5/20
CVD in developing countries
Economic transition urbanisation, industrialisation andglobalisation bring about lifestyle changes that promoteheart disease.
These risk factors include tobacco use, physicalinactivity, unhealthy diet.
Life expectancy in developing countries is rising sharplyand people are exposed to these risk factors for longer
periods. Newly merging CVD risk factors like low birth weight,
folate deficiency and infections are also more frequentamong the poorest in low and middle income countries.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
6/20
Social and economic consequences
Clinical care of CVD is costly and prolonged.
These direct costs divert the scarce family and societal
resources to medical care.
CVD affects individuals in their peak mid life years disrupting
the future of the families dependant on them and
undermining the development of nations by depriving
valuable human resources in their most productive years.
In developed countries lower socioeconomic groups have
greater prevalence of risk factors, higher incidence of disease
and higher mortality.
In developing countries as the CVD epidemic matures the
burden will shift to the lower socioeconomic groups.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
7/20
To effectively control CVD risk factors and
to reduce the burden of the fast growing
cardiovascular disease (CVD) epidemic
particularly in developing countries.
Goal of the WHO Global Strategy
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
8/20
Key areas of work
Reduce major CVD risk factors and their social and
economic determinants through community based
programmes for integrated prevention of NCDs.
Development of standards of care and cost-effective case
management for CVD.
Global action to enhance the capacity of countries to meet
the health care needs of CVD.
Developing feasible surveillance methods to assess the
pattern and trends of major CVDs and risk factors and to
monitor prevention and control initiatives.
Developing effective inter-country, interregional and global
networks and partnerships for concerted global action.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
9/20
Integrated Management
of Cardiovascular Risk
Cardiovascular disease (CVD) is a leading cause of mortality andis responsible for one-third of all global deaths. Nearly 85% ofthe global mortality and disease burden from CVD is borne bylow- and middle-income countries.
In India, for example, approximately 53% of CVD deaths are inpeople younger than 70 years of age; in China, the correspondingfigure is 35%. The majority of the estimated 32 million heartattacks and strokes that occur every year are caused by one or
more cardiovascular risk factorshypertension, diabetes,smoking, high levels of blood lipids, and physical inactivityandmost of these CVD events are preventable if meaningful actionis taken against these risk factors.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
10/20
CVD is an important cause of global morbidity
and in five of the six WHO Regions it is the
leading cause of mortality.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
11/20
Cardiovascular Risk
Risk factors i.e. smoking, unhealthy diet andphysical inactivity are expressed as hypertension,diabetes, obesity and high blood lipid levels, and
together contribute to the total cardiovascularrisk and are the root causes of the global CVDepidemic
Risk factors account for 75% of the CVDepidemic worldwide
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
12/20
Heart attacks and strokes are leading causes of death and
disability, they represent only the tip of an iceberg.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
13/20
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
14/20
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
15/20
CVDs are responsible for the deaths of 17
million people each year, or approximately
onethird of global deaths annually.
Hypertension is the most prevalent CVD,
affecting at least 600 million people, and is an
important contributor to cardiovascular
mortality and morbidity
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
16/20
Hypertension as an entry point to cardiovascular
risk management About 15%37% of the adult population worldwide is
afflicted with hypertension
In general, hypertension prevalence is higher in urban settingscompared to rural settings
Data from World Health Report 2002 indicate thathypertension is the third most important contributor to theglobal disease burden among the six risk factors:underweight, unsafe sex, hypertension, unsafe water, tobaccoand alcohol.
treating hypertension has been associated with a 35%40%reduction in the risk of stroke and a reduction of at least 15%in the risk of myocardial infarction.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
17/20
a paradigm shift from treatment of hypertension
to management of comprehensive cardiovascular
risk. Cost-effectiveness of treating hypertension is
also determined by the overall cardiovascular riskand not by blood pressure alone
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
18/20
Barriers to cardiovascular risk
management Health policy
The overriding barrier to CVD risk-management programmes in low- andmiddle-income countries is that there are no formal policies that targetCVD as a major health issue.
In 2001, a survey of 167 countries in the six WHO Regions found that57% of the countries lacked a noncommunicable disease policy, and 65%had no CVD plan
Health-care systems under equipped health facilities; a lack of continuity between primary
health care and the secondary- and tertiary-care sectors; poorly-developedinformation systems; a lack of awareness of the potential health benefitsand cost savings of CVD programmes; and the influence of commercialinterests on resource allocation.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
19/20
Barriers to cardiovascular risk
management Health-care providers
the lack of personnel with appropriate training and skills, and an alreadyoverburdened workforce.
In the WHO global capacity assessment survey, healthcare professionalsreceived no training in the management of noncommunicable diseases in
about one-half of the 167 countries surveyed.
Patients, families and the community A comprehensive CVD risk-management programme relies upon
individual patients adhering to daily drug treatments, accepting lifestyleadvice, and returning for follow-up assessments
Patient adherence needs to be enhanced through the support of familymembers and the community
Families and communities need to be empowered to actively participatein patient care, through health education and through communitymobilization programmes.
7/31/2019 1. Strategic Priorities of the WHO Cardiovascular Disease Programme
20/20
Menurut Menkes CVD telah menjadi salah satu
masalah penting kesehatan masyarakat dan
penyebab kematian utama
WHO, memperkirakan pa tahun 2030, 23,6 juta
orang meninggal karena CVD
Riskesdas (2007), menunjukkan prevalensi
penyakit jantung 7,2%
Penyakit jantung Iskemik : 5,1% dari seluruh
penyebab kematian dan penyakit jantung 4,6%
dari seluruh kematian